239 related articles for article (PubMed ID: 21718306)
1. Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.
Renoir T; Pang TY; Zajac MS; Chan G; Du X; Leang L; Chevarin C; Lanfumey L; Hannan AJ
Br J Pharmacol; 2012 Mar; 165(5):1375-89. PubMed ID: 21718306
[TBL] [Abstract][Full Text] [Related]
2. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.
Renoir T; Zajac MS; Du X; Pang TY; Leang L; Chevarin C; Lanfumey L; Hannan AJ
PLoS One; 2011; 6(7):e22133. PubMed ID: 21760962
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.
Renoir T; Pang TY; Mo C; Chan G; Chevarin C; Lanfumey L; Hannan AJ
J Physiol; 2013 Jan; 591(1):41-55. PubMed ID: 23045340
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
5. Ethanol induced antidepressant-like effect in the mouse forced swimming test: modulation by serotonergic system.
Jain NS; Kannamwar U; Verma L
Psychopharmacology (Berl); 2017 Feb; 234(3):447-459. PubMed ID: 27838747
[TBL] [Abstract][Full Text] [Related]
6. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.
Peng Q; Masuda N; Jiang M; Li Q; Zhao M; Ross CA; Duan W
Exp Neurol; 2008 Mar; 210(1):154-63. PubMed ID: 18096160
[TBL] [Abstract][Full Text] [Related]
8. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
[TBL] [Abstract][Full Text] [Related]
9. Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.
Jacobsen JP; Siesser WB; Sachs BD; Peterson S; Cools MJ; Setola V; Folgering JH; Flik G; Caron MG
Mol Psychiatry; 2012 Jul; 17(7):694-704. PubMed ID: 21537332
[TBL] [Abstract][Full Text] [Related]
10. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
Bortolozzi A; Castañé A; Semakova J; Santana N; Alvarado G; Cortés R; Ferrés-Coy A; Fernández G; Carmona MC; Toth M; Perales JC; Montefeltro A; Artigas F
Mol Psychiatry; 2012 Jun; 17(6):612-23. PubMed ID: 21808255
[TBL] [Abstract][Full Text] [Related]
11. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
12. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
Mato S; Aso E; Castro E; Martín M; Valverde O; Maldonado R; Pazos A
J Neurochem; 2007 Dec; 103(5):2111-20. PubMed ID: 17944876
[TBL] [Abstract][Full Text] [Related]
13. Estradiol-sertraline synergy in ovariectomized rats.
Sell SL; Craft RM; Seitz PK; Stutz SJ; Cunningham KA; Thomas ML
Psychoneuroendocrinology; 2008 Sep; 33(8):1051-60. PubMed ID: 18650020
[TBL] [Abstract][Full Text] [Related]
14. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
Wang R; Xu Y; Wu HL; Li YB; Li YH; Guo JB; Li XJ
Eur J Pharmacol; 2008 Jan; 578(1):43-50. PubMed ID: 17942093
[TBL] [Abstract][Full Text] [Related]
15. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors.
Pobbe RL; Zangrossi H; Blanchard DC; Blanchard RJ
Eur Neuropsychopharmacol; 2011 Apr; 21(4):306-15. PubMed ID: 20570114
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the Dorsal Hippocampus 5-HT1A Receptors in the Regulation of Depressive-Like Behaviors in Hemiparkinsonian Rats.
Jiang YF; Liu J; Yang J; Guo Y; Hu W; Zhang J; La XM; Xie W; Wang HS; Zhang L
Neuropsychobiology; 2020; 79(3):198-207. PubMed ID: 31940619
[TBL] [Abstract][Full Text] [Related]
17. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
18. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.
Zanelati TV; Biojone C; Moreira FA; Guimarães FS; Joca SR
Br J Pharmacol; 2010 Jan; 159(1):122-8. PubMed ID: 20002102
[TBL] [Abstract][Full Text] [Related]
20. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
